2, 6 It is the goal of this review to provide answers to questions regarding the use of pharmacotherapy for cluster A personality disorders and bring the reader up to date regarding what is known and unknown about the effectiveness of this practice. The risks and benefits of pharmacotherapy must be carefully considered, especially in a situation where expected benefits may be modest. 2, 6 The use of pharmacotherapy is adjunctive, with the goal of providing enough stabilization to make it easier or possible for the patient to engage in psychosocial interventions. These dimensions include affective dysregulation (eg, angry, anxious, depressed, labile mood), cognitive-perceptual symptoms (eg, auditory, visual hallucinations), and impulsive aggression (eg, self-cutting, suicidality). Pharmacotherapy for personality disorders tends to be symptom specific, focusing on dimensions of personality believed most likely to be responsive to pharmacotherapy and that typically warrant the most clinical attention. At this time, treatment with pharmacologic agents is based on theory rather than evidence. Further research is needed to evaluate specific pharmacologic treatment in the cluster A personality disorders. Studies evaluating the use of olanzapine, risperidone, haloperidol, fluoxetine, and thiothixene did yield beneficial results however, treatment with such agents should be considered on a case-by-case basis.ĭiscussion: Most of the literature analyzed in this review presented theoretical ideas of what may constitute the neurobiologic factors of personality and what treatments may address these aspects. Literature was available for pharmacologic treatment of schizotypal personality disorder. Results: Minimal evidence regarding pharmacotherapy in paranoid and schizoid personality disorders was found. There were no exclusions in terms of time frame from article publication or country of publication, in order to provide a comprehensive analysis however, only articles that contained information on the cluster A disorders were included. Methods: A Medline/PubMed and Ovid search was conducted to identify literature on the psychopharmacology of paranoid personality disorder, schizoid personality disorder, and schizotypal personality disorder. The purpose of this review is to evaluate the current literature for pharmacologic treatments for the cluster A personality disorders. The quality of life may also be reduced in these individuals, which provokes the question of how to treat patients with these personality disorders. Patients with cluster A personality disorders tend to be isolative and avoid relationships. Specifically, the cluster A personality disorders include paranoid personality disorder, schizoid personality disorder, and schizotypal personality disorder. Gain the ability to better understand, communicate, and form a therapeutic relationship with individuals who are diagnosed with personality disordersĪpproved by the APNA Board of Directors February 2022.Introduction: A personality disorder is a pervasive and enduring pattern of behaviors that impacts an individual's social, occupational, and overall functioning.Develop an awareness of the prevalence and presentation of each disorder.Understand the complexities of the disorders.The essentials document and supplemental case studies below will help you: This resource is intended for use in inpatient and outpatient settings by registered nurses, advanced practice nurses, and nurse educators. It organizes the diagnosis of personality disorder in three parts: Cluster A, Cluster B, and Cluster C. This resource was created by the APNA Personality Disorders Task Forces to assist nurses in caring for patients whose symptoms and struggles have caused them to meet the criteria for the diagnosis of a personality disorder, as well as to ultimately help nurses avoid judgment and decrease stigma. The Essentials of Caring for Persons Who Are Diagnosed with Personality Disorders APNA Board of Directors Student Scholars Application Walkthrough.APNA Board of Directors Student Scholars Recipients.2020 APNA Award for Excellence in Research.2020 APNA Award for Excellence in Practice – RN.2020 APNA Award for Distinguished Service.2020 APNA Psychiatric Nurse of the Year. APNA Research Grant Proposal Submission Walkthrough.APNA Research Grants Application Checklist.APNA Clinical Psychopharmacology Institute.Suicide Prevention Training: Acute Care.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |